Skip to content

An interventional study of resistant starch on normal-weight and overweight/obese subjects

An interventional study of resistant starch on normal-weight and overweight/obese subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TTRCC-13003333
Enrollment
Unknown
Registered
2013-07-03
Start date
2013-07-03
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Normal-weight group :Resistant starch or control starch
Overweight or obese group:Resistant starch or control starch

Sponsors

Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Normal-weight group: Sign informed consent; Chinese; Aged between 18 to 55 years old; 18.5 kg/m2 < BMI <24 kg /m2; Waist circumference< 85 cm in men and <80 cm in women. Overweight or obese group: Sign informed consent; Chinese; Aged between 18 to 55 years old; Overweight or obesity, as defined by BMI = 24 kg/m2 or waist circumference = 85 cm in men and = 80 cm in women.

Exclusion criteria

Exclusion criteria: Normal-weight group: Known impaired glucose regulation diabetes; Known hyperthyroidism, hypothyroidism, digestive system disease, cardio-cerebrovascular disease, or any other chronic disease; Using antibiotics or probiotic supplements 3 weeks prior to the study; Regularly use of prescription drugs (regular contraceptives are excluded); Participating or have participated in other clinical trials 4 weeks before the study. Overweight or obese group: Unwilling to accept randomization Acute illness or using the antibiotics 3 weeks prior to the study; Known hyperthyroidism, hypothyroidism, diabetes, digestive system disease, cardio-cerebrovascular disease, or any other chronic disease; Current treatment with systemic corticosteroids or medications which may affect glucose metabolism; Have used antibiotics or probiotic supplements 3 weeks before the study or using during the study; Regularly use of prescription drugs (regular use of contraceptives is excluded) or Chinese and Western medicine; Participating or have participated in other clinical trials 4 weeks before the study.

Design outcomes

Primary

MeasureTime frame
body weight;visceral fat area;

Secondary

MeasureTime frame
subcutaneous fat area;body fat;waist circumference;lipid profiles;insulin sensitivity;metabolome;gut microbiome;

Countries

China

Contacts

Public ContactWeiping Jia

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

wpjia@yahoo.com+86 021-64369181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026